Suchergebnisse - "Personeni, Nicola"

PubPharm (21)

1

Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma : An international observational study

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2023

von Talbot, T. | D'Alessio, A. | Pinter, M. | +33

CommentIn: Liver Int. 2023 Mar;43(3):528-530. - PMID 36808694

2

Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2022

von Vithayathil, M. | D'Alessio, A. | Fulgenzi, C. | +32

CommentIn: Liver Int. 2022 Nov;42(11):2352-2353. - PMID 36162086

3

Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice : Results of the AB-real study

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Fulgenzi, C. | Cheon, J. | D'Alessio, A. | +34

4

Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis : A real-world study

enthalten in: Hepatology (Baltimore, Md.) | 2022

von D'Alessio, A. | Fulgenzi, C. | Nishida, N. | +32

CommentIn: Hepatology. 2022 Oct;76(4):906-908. - PMID 35491442

5

Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC

enthalten in: Hepatology communications | 2022

von Sharma, R. | Pillai, A. | Marron, T. | +26

6

Temozolomide Treatment Alters Mismatch Repair and Boosts Mutational Burden in Tumor and Blood of Colorectal Cancer Patients

enthalten in: Cancer discovery | 2022

von Crisafulli, G. | Sartore-Bianchi, A. | Lazzari, L. | +23

CommentIn: Cancer Discov. 2022 Jul 6;12(7):1612-1614. - PMID 35791694

7

Exploring novel avenues for neoadjuvant treatment of hepatocellular carcinoma

enthalten in: The lancet. Gastroenterology & hepatology | 2022

von Personeni, N. | Rimassa, L.

CommentOn: Lancet Gastroenterol Hepatol. 2022 Mar;7(3):208-218. - PMID 35065057

8

Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score

enthalten in: Journal of hepatology | 2022

von Scheiner, B. | Pomej, K. | Kirstein, M. | +38

CommentIn: J Hepatol. 2022 Apr;76(4):987-988. - PMID 34780876

9

Treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer : Evidence from an FDA pooled analysis of landmark clinical trials with validation from routine practice

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Pinato, D. | Marron, T. | Mishra-Kalyani, P. | +39

10

Atezolizumab plus bevacizumab for unresectable or metastatic hepatocellular carcinoma

enthalten in: Expert review of anticancer therapy | 2021

von D'Alessio, A. | Cammarota, A. | Zanuso, V. | +3